Multifunctional graphene oxide nanoparticles for drug delivery in cancer

Recent advancements in nanotechnology have enabled us to develop sophisticated multifunctional nanoparticles or nanosystems for targeted diagnosis and treatment of several illnesses, including cancers. To effectively treat any solid tumor, the therapy should preferably target just the malignant cell...

Full description

Saved in:
Bibliographic Details
Published inJournal of controlled release Vol. 350; pp. 26 - 59
Main Authors Itoo, Asif Mohd, Vemula, Sree Lakshmi, Gupta, Mahima Tejasvni, Giram, Mahesh Vilasrao, Kumar, Sangishetty Akhil, Ghosh, Balaram, Biswas, Swati
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.10.2022
Subjects
Anticancer
Cancer
Drug delivery
Graphene oxide
Nanomedicine
Photothermal
Graphene oxide
Drug delivery
Anticancer
Nanomedicine
Photothermal
Cancer
Online AccessGet full text

Cover

More Information
Summary:Recent advancements in nanotechnology have enabled us to develop sophisticated multifunctional nanoparticles or nanosystems for targeted diagnosis and treatment of several illnesses, including cancers. To effectively treat any solid tumor, the therapy should preferably target just the malignant cells/tissue with minor damage to normal cells/tissues. Graphene oxide (GO) nanoparticles have gained considerable interest owing to their two-dimensional planar structure, chemical/mechanical stability, excellent photosensitivity, superb conductivity, high surface area, and good biocompatibility in cancer therapy. Many compounds have been functionalized on the surface of GO to increase their biological applications and minimize cytotoxicity. The review presents an overview of the physicochemical characteristics, strategies for various modifications, toxicity and biocompatibility of graphene and graphene oxide, current trends in developing GO-based nano constructs as a drug delivery cargo and other biological applications, including chemo-photothermal therapy, chemo-photodynamic therapy, bioimaging, and theragnosis in cancer. Further, the review discusses the challenges and opportunities of GO, GO-based nanomaterials for the said applications. Overall, the review focuses on the therapeutic potential of strategically developed GO nanomedicines and comprehensively discusses their opportunities and challenges in cancer therapy. [Display omitted]
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0168-3659
1873-4995
DOI:10.1016/j.jconrel.2022.08.011